Annual report pursuant to Section 13 and 15(d)

Note 8 - Stock-based Incentive Plans

v3.23.1
Note 8 - Stock-based Incentive Plans
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Compensation and Employee Benefit Plans [Text Block]

8.

STOCK-BASED INCENTIVE PLANS

 

The Super League 2014 Stock Option and Incentive Plan (the “Plan”) was approved by the Board of Directors and the stockholders of Super League in October 2014. The Plan was subsequently amended in May 2015, May 2016, July 2017 and October 2018. The Plan allows grants of stock options, stock awards and performance shares with respect to common stock of the Company to eligible individuals, which generally includes directors, officers, employees, advisors and consultants. The Plan provides for both the direct award and sale of shares of common stock and for the grant of options to purchase shares of common stock. Options granted under the Plan include non-statutory options as well as incentive options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended.

 

 

The Board of Directors administers the Plan and determines which eligible individuals are to receive option grants or stock issuances under the Plan, the times when the grants or issuances are to be made, the number of shares of common stock subject to each grant or issuance, the status of any granted option as either an incentive stock option or a non-statutory stock option under the federal tax laws, the vesting schedule to be in effect for the option grant or stock issuance and the maximum term for which any granted option is to remain outstanding. The exercise price of options is generally equal to the fair market value of common stock of the Company on the date of grant. Options generally begin to be exercisable six months to one year after grant and typically expire 10 years after grant. Stock options and restricted shares generally vest over two to four years (generally representing the requisite service period). The Plan terminates automatically on July 1, 2027. The Plan provides for the following programs:

 

 

Option Grants

 

Under the discretionary option grant program, the Company’s compensation committee of the Board of Directors may grant (1) non-statutory options to purchase shares of common stock to eligible individuals in the employ or service of Super League or its affiliates (including employees, non-employee members of the Board of Directors and consultants) at an exercise price not less than 85% of the fair market value of such shares on the grant date, and (2) incentive stock options to purchase shares of common stock to eligible employees at an exercise price not less than 100% of the fair market value of such shares on the grant date (not less than 110% of fair market value if such employee actually or constructively owns more than 10% of Super League’s voting stock or the voting stock of any of its subsidiaries).

 

 

Stock Awards or Sales

 

Under the stock award or sales program, eligible individuals may be issued shares of common stock of the Company directly, upon the attainment of performance milestones or the completion of a specified period of service or as a bonus for past services. Under this program, the purchase price for the shares will not be less than 100% of the fair market value of the shares on the date of issuance, and payment may be in the form of cash or past services rendered. Eligible individuals will have no stockholder rights with respect to any unvested restricted shares or restricted stock units issued to them under the stock award or sales program; however, eligible individuals will have the right to receive any regular cash dividends paid on such shares.

 

The initial reserve under the Plan was 583,334 shares of common stock, which reserve was subsequently increased to 1,000,000 shares upon stockholders’ approval in May 2016. In July 2017, the Company amended and restated the Plan to increase the number of shares of common stock reserved thereunder from 1,000,000 shares to 1,500,000 shares. In October 2018, the Company amended and restated the Plan to increase the number of shares of common stock reserved thereunder from 1,500,000 shares to 1,833,334 shares. In July 2020, the Company’s shareholders approved an amendment to the Plan to increase the number of shares authorized for issuance from 1,833,334 to 2,583,334. In May 2021, the Company’s shareholders approved an amendment to the Plan to increase the number of shares authorized for issuance from 2,583,334 to 5,000,000. In June 2022, the Company’s shareholders approved an amendment to the Plan to increase the number of shares authorized for issuance from 5,000,000 to 6,250,000. As of December 31, 2022, 1,139,074 shares remained available for issuance under the Plan.

 

Super League issues new shares of common stock upon the exercise of stock options, the grant of restricted stock, or the delivery of shares pursuant to vested restricted stock units. The compensation committee of the Board of Directors may amend or modify the Plan at any time, subject to any required approval by the stockholders of the Company, pursuant to the terms therein. In the event that any outstanding option or other right for any reason expires or is canceled or otherwise terminated, the shares allocable to the unexercised portion of such option or other right is returned and available for the purposes of this Plan.

 

Stock Options

 

The fair value of stock options granted was estimated on their respective grant dates using the Black-Scholes-Merton option pricing model and the following weighted-average assumptions for the years ended December 31, 2022 and 2021:

 

   

2022

   

2021

 

Expected Volatility

    95 %     95 %

Risk–free interest rate

    2.89 %     .99 %

Dividend yield

    - %     - %

Expected life of options (in years)

    6.08       5.86  

 

The expected volatility assumption for purposes of determining the fair value of stock options for the periods presented was estimated based on reference to the historical stock price volatility of the Company and a representative peer group for the applicable estimated term.

 

 

A summary of stock option activity for the year ended December 31, 2022 is as follows:

 

           

Weighted-Average

         
   

Options (#)

   

Exercise

Price Per Share ($)

   

Remaining

Contractual Term (Years)

   

Aggregate

Intrinsic Value ($)

 
                                 

Outstanding at December 31, 2021

    2,433,000     $ 5.18             $ 246,000  

Granted

    239,000     $ 1.51                  

Exercised

    -    

$

-                  

Canceled / forfeited

    (194,000

)

  $ 4.23                  

Outstanding at December 31, 2022

    2,478,000     $ 4.90       6.87     $ 4,000  

Vested and exercisable at December 31, 2022

    1,569,000     $ 5.80       5.99     $ 4,000  

 

The weighted-average grant date fair value of stock options granted during the years ended December 31, 2022 and 2021 was $1.17 and $3.40, respectively. The aggregate fair value of stock options that vested during the years ended December 31, 2022 and 2021 was $1,726,000 and $720,000, respectively. As of December 31, 2022, the total unrecognized compensation expense related to non-vested stock option awards was $2,204,000, which is expected to be recognized over a weighted-average term of approximately 2.16 years.

 

Restricted Stock Units

 

The following table summarizes non-vested restricted stock unit activity for the year ended December 31, 2022:

 

   

2014 Plan Activity

    Outside of the 2014 Plan Activity    

Totals

 

Non-vested Restricted Stock

 

Restricted

Stock

Units (#)

   

Weighted Average

Grant Date

Fair Value ($)

   

Restricted

Stock

Units (#)

   

Weighted Average

Grant Date

Fair Value ($)

   

Restricted

Stock

Units (#)

   

Weighted Average

Grant Date

Fair Value ($)

 
                                                 
                                                 

At December 31, 2021

    361,000     $ 4.92       -     $ -       361,000     $ 4.92  

Granted

    1,940,000     $ 1.57       140,000     $ 0.91       2,080,000     $ 1.52  

Vested

    (257,000

)

  $ 4.50       (105,000

)

  $ 0.91       (362,000

)

  $ 3.46  

Canceled

    (32,000

)

  $ 1.87       -     $ -       (32,000

)

  $ 1.87  

At December 31, 2022

    2,012,000     $ 1.78       35,000     $ 0.91       2,047,000     $ 1.77  

 

As of December 31, 2022, the total unrecognized compensation expense related to non-vested restricted stock units was $983,000 which will be recognized over a weighted-average term of approximately one year.

 

On January 1, 2022, the Company issued 1,350,000 performance stock units (“PSUs”) (included in the table above) under the Company’s 2014 Amended and Restated Stock Option and Incentive Plan, which vest in five equal increments of 270,000 PSUs, based on satisfaction of the following vesting conditions during the three-year period commencing on January 1, 2022:

 

 

(i)

the Company’s stock price equaling $4.75 per share based on 60-day volume weighted average price (“VWAP”);

 

(ii)

the Company’s stock price equaling $6.00 per share based on 60-day VWAP;

 

(iii)

the Company’s stock price equaling $7.00 per share based on 60-day VWAP;

 

(iv)

the Company’s stock price equaling $8.00 per share based on 60-day VWAP; and

 

(v)

the Company’s stock price equaling $9.00 per share based on 60-day VWAP.

 

 

A condition affecting the exercisability or other pertinent factors used in determining the fair value of an award that is based on an entity achieving a specified share price constitutes a market condition pursuant ASC 718. Noncash stock compensation expense related to the PSUs totaled $2,142,000 for the year ended December 31, 2022.

 

During the year ended December 31, 2022, the Company issued 170,000 restricted stock units (included in the table above) to nonemployees for services (“Nonemployee RSUs”). The weighted average grant date fair value of the Nonemployee RSUs granted during the year ended December 13, 2022 was $0.91. Compensation expense for Nonemployee RSUs for the year ended December 31, 2022 totaled $131,000. As of December 31, 2022, the total unrecognized compensation expense related to Nonemployee RSUs was $24,000, which will be recognized in the first quarter of fiscal 2023.

 

Warrants Issued to Employees and Nonemployees for Services

 

A summary of employee and nonemployee warrant activity (outside of the Plan) for the year ended December 31, 2022 is as follows:

 

           

Weighted-Average

         
   

Warrants (#)

   

Exercise

Price Per Share ($)

   

Remaining

Contractual Term (Years)

   

Aggregate

Intrinsic Value ($)

 
                                 

Outstanding at December 31, 2021

    781,000     $ 10.26                  

Granted

    500,000     $ 0.67             $ -  

Expired

    (116,000

)

  $ 10.80             $ -  

Outstanding at December 31, 2022

    1,165,000     $ 6.09       4.78     $ -  

Vested and exercisable as of December 31, 2022

    665,000     $ 10.16       4.78     $ -  

 

The weighted-average grant date fair value of common stock purchase warrants (“Warrants”) granted during the year ended December 31, 2022 was $0.50. No Warrants were granted to employees or non-employees in exchange for services performed during the year ended December 31, 2021. No Warrants vested during the years ended December 31, 2022 and 2021. As of December 31, 2022, the total unrecognized compensation expense related to Warrants was $228,000.

 

On December 1, 2022, the Company issued 500,000 warrants (included in the table above) to a third-party for nonemployee investor relations services. The warrants have an exercise price of $0.67, a grant date fair value of $0.50, vest in twelve equal monthly installments commencing on the grant date and expire five years from the grant date. Compensation expense included in the statement of operations for the year ended December 31, 2022 totaled $20,000.

 

Noncash Stock Compensation Expense

 

Noncash stock-based compensation expense for the periods presented was comprised of the following:

 

   

2022

   

2021

 

Stock options

  $ 1,278,000     $ 1,148,000  

Warrants

    20,000       -  

Restricted stock units

    2,965,000       1,233,000  

Total noncash stock compensation expense

  $ 4,263,000     $ 2,381,000  

 

Noncash stock-based compensation expense for the periods presented was included in the following financial statement line items:

 

   

2022

   

2021

 

Sales, marketing and advertising

  $ 1,079,000     $ 934,000  

Engineering, technology and development

    389,000       288,000  

General and administrative

    2,795,000       1,159,000  

Total noncash stock compensation expense

  $ 4,263,000     $ 2,381,000